Skip to main content
Clinical Trials/NL-OMON35170
NL-OMON35170
Recruiting
Not Applicable

Colonization and infection of the respiratory tract by Mycoplasma pneumoniae in children - MymIC

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
common cold
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
1000
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • · Age: ³3 months and \<\= 16 years
  • · Clinical signs and symptoms of community\-acquired upper or lower respiratory tract infection (i.e. cough, rhinitis, sore throat, wheezing and fever).
  • · Written informed consent;Group B (control group)
  • · Age: ³3 months and \<\= 16 years
  • · Written informed consent
  • · Healthy controls: absence for ³1 week of clinical signs and symptoms of community\-acquired upper or lower respiratory tract infection (i.e. cough, rhinitis, sore throat, wheezing and fever)

Exclusion Criteria

  • Severe concomitant disease (chronic lung disease, neoplasia, liver or kidney disease, immunodeficiency, cardiovascular disease, psychomotor impairment). Nosocomial infection. Use of antibiotics in the 48 hours that preceded enrollment or azithromycin within 1 week before enrollment

Outcomes

Primary Outcomes

Not specified

Similar Trials